Cargando…
Point‐of‐care oral cytology tool for the screening and assessment of potentially malignant oral lesions
BACKGROUND: The effective detection and monitoring of potentially malignant oral lesions (PMOL) are critical to identifying early‐stage cancer and improving outcomes. In the current study, the authors described cytopathology tools, including machine learning algorithms, clinical algorithms, and test...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078980/ https://www.ncbi.nlm.nih.gov/pubmed/32032477 http://dx.doi.org/10.1002/cncy.22236 |
_version_ | 1783507732321533952 |
---|---|
author | McRae, Michael P. Modak, Sayli S. Simmons, Glennon W. Trochesset, Denise A. Kerr, A. Ross Thornhill, Martin H. Redding, Spencer W. Vigneswaran, Nadarajah Kang, Stella K. Christodoulides, Nicolaos J. Murdoch, Craig Dietl, Steven J. Markham, Roger McDevitt, John T. |
author_facet | McRae, Michael P. Modak, Sayli S. Simmons, Glennon W. Trochesset, Denise A. Kerr, A. Ross Thornhill, Martin H. Redding, Spencer W. Vigneswaran, Nadarajah Kang, Stella K. Christodoulides, Nicolaos J. Murdoch, Craig Dietl, Steven J. Markham, Roger McDevitt, John T. |
author_sort | McRae, Michael P. |
collection | PubMed |
description | BACKGROUND: The effective detection and monitoring of potentially malignant oral lesions (PMOL) are critical to identifying early‐stage cancer and improving outcomes. In the current study, the authors described cytopathology tools, including machine learning algorithms, clinical algorithms, and test reports developed to assist pathologists and clinicians with PMOL evaluation. METHODS: Data were acquired from a multisite clinical validation study of 999 subjects with PMOLs and oral squamous cell carcinoma (OSCC) using a cytology‐on‐a‐chip approach. A machine learning model was trained to recognize and quantify the distributions of 4 cell phenotypes. A least absolute shrinkage and selection operator (lasso) logistic regression model was trained to distinguish PMOLs and cancer across a spectrum of histopathologic diagnoses ranging from benign, to increasing grades of oral epithelial dysplasia (OED), to OSCC using demographics, lesion characteristics, and cell phenotypes. Cytopathology software was developed to assist pathologists in reviewing brush cytology test results, including high‐content cell analyses, data visualization tools, and results reporting. RESULTS: Cell phenotypes were determined accurately through an automated cytological assay and machine learning approach (99.3% accuracy). Significant differences in cell phenotype distributions across diagnostic categories were found in 3 phenotypes (type 1 [“mature squamous”], type 2 [“small round”], and type 3 [“leukocytes”]). The clinical algorithms resulted in acceptable performance characteristics (area under the curve of 0.81 for benign vs mild dysplasia and 0.95 for benign vs malignancy). CONCLUSIONS: These new cytopathology tools represent a practical solution for rapid PMOL assessment, with the potential to facilitate screening and longitudinal monitoring in primary, secondary, and tertiary clinical care settings. |
format | Online Article Text |
id | pubmed-7078980 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70789802020-03-19 Point‐of‐care oral cytology tool for the screening and assessment of potentially malignant oral lesions McRae, Michael P. Modak, Sayli S. Simmons, Glennon W. Trochesset, Denise A. Kerr, A. Ross Thornhill, Martin H. Redding, Spencer W. Vigneswaran, Nadarajah Kang, Stella K. Christodoulides, Nicolaos J. Murdoch, Craig Dietl, Steven J. Markham, Roger McDevitt, John T. Cancer Cytopathol Original Articles BACKGROUND: The effective detection and monitoring of potentially malignant oral lesions (PMOL) are critical to identifying early‐stage cancer and improving outcomes. In the current study, the authors described cytopathology tools, including machine learning algorithms, clinical algorithms, and test reports developed to assist pathologists and clinicians with PMOL evaluation. METHODS: Data were acquired from a multisite clinical validation study of 999 subjects with PMOLs and oral squamous cell carcinoma (OSCC) using a cytology‐on‐a‐chip approach. A machine learning model was trained to recognize and quantify the distributions of 4 cell phenotypes. A least absolute shrinkage and selection operator (lasso) logistic regression model was trained to distinguish PMOLs and cancer across a spectrum of histopathologic diagnoses ranging from benign, to increasing grades of oral epithelial dysplasia (OED), to OSCC using demographics, lesion characteristics, and cell phenotypes. Cytopathology software was developed to assist pathologists in reviewing brush cytology test results, including high‐content cell analyses, data visualization tools, and results reporting. RESULTS: Cell phenotypes were determined accurately through an automated cytological assay and machine learning approach (99.3% accuracy). Significant differences in cell phenotype distributions across diagnostic categories were found in 3 phenotypes (type 1 [“mature squamous”], type 2 [“small round”], and type 3 [“leukocytes”]). The clinical algorithms resulted in acceptable performance characteristics (area under the curve of 0.81 for benign vs mild dysplasia and 0.95 for benign vs malignancy). CONCLUSIONS: These new cytopathology tools represent a practical solution for rapid PMOL assessment, with the potential to facilitate screening and longitudinal monitoring in primary, secondary, and tertiary clinical care settings. John Wiley and Sons Inc. 2020-02-07 2020-03 /pmc/articles/PMC7078980/ /pubmed/32032477 http://dx.doi.org/10.1002/cncy.22236 Text en © 2020 The Authors. Cancer Cytopathology published by Wiley Periodicals, Inc. on behalf of American Cancer Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles McRae, Michael P. Modak, Sayli S. Simmons, Glennon W. Trochesset, Denise A. Kerr, A. Ross Thornhill, Martin H. Redding, Spencer W. Vigneswaran, Nadarajah Kang, Stella K. Christodoulides, Nicolaos J. Murdoch, Craig Dietl, Steven J. Markham, Roger McDevitt, John T. Point‐of‐care oral cytology tool for the screening and assessment of potentially malignant oral lesions |
title | Point‐of‐care oral cytology tool for the screening and assessment of potentially malignant oral lesions |
title_full | Point‐of‐care oral cytology tool for the screening and assessment of potentially malignant oral lesions |
title_fullStr | Point‐of‐care oral cytology tool for the screening and assessment of potentially malignant oral lesions |
title_full_unstemmed | Point‐of‐care oral cytology tool for the screening and assessment of potentially malignant oral lesions |
title_short | Point‐of‐care oral cytology tool for the screening and assessment of potentially malignant oral lesions |
title_sort | point‐of‐care oral cytology tool for the screening and assessment of potentially malignant oral lesions |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078980/ https://www.ncbi.nlm.nih.gov/pubmed/32032477 http://dx.doi.org/10.1002/cncy.22236 |
work_keys_str_mv | AT mcraemichaelp pointofcareoralcytologytoolforthescreeningandassessmentofpotentiallymalignantorallesions AT modaksaylis pointofcareoralcytologytoolforthescreeningandassessmentofpotentiallymalignantorallesions AT simmonsglennonw pointofcareoralcytologytoolforthescreeningandassessmentofpotentiallymalignantorallesions AT trochessetdenisea pointofcareoralcytologytoolforthescreeningandassessmentofpotentiallymalignantorallesions AT kerraross pointofcareoralcytologytoolforthescreeningandassessmentofpotentiallymalignantorallesions AT thornhillmartinh pointofcareoralcytologytoolforthescreeningandassessmentofpotentiallymalignantorallesions AT reddingspencerw pointofcareoralcytologytoolforthescreeningandassessmentofpotentiallymalignantorallesions AT vigneswarannadarajah pointofcareoralcytologytoolforthescreeningandassessmentofpotentiallymalignantorallesions AT kangstellak pointofcareoralcytologytoolforthescreeningandassessmentofpotentiallymalignantorallesions AT christodoulidesnicolaosj pointofcareoralcytologytoolforthescreeningandassessmentofpotentiallymalignantorallesions AT murdochcraig pointofcareoralcytologytoolforthescreeningandassessmentofpotentiallymalignantorallesions AT dietlstevenj pointofcareoralcytologytoolforthescreeningandassessmentofpotentiallymalignantorallesions AT markhamroger pointofcareoralcytologytoolforthescreeningandassessmentofpotentiallymalignantorallesions AT mcdevittjohnt pointofcareoralcytologytoolforthescreeningandassessmentofpotentiallymalignantorallesions |